The result of anti-IFN α/ω was replicated in independent cohorts, allowing to mechanistically link the presence of auto-antibodies to a dampened IFN signature at the transcriptomic level as well as to lymphopenia, higher systemic inflammation indexes and poorer outcomes (78–80). This evidence concerns the gene IFNA1 and lymphopenia.